| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $7.10B | $6.65B | $6.67B |
| YoY Revenue Growth % | +6.8% | -0.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$61.4M | $1.53B | $259.6M |
| Operating Margin % | -0.9% | 23.0% | 3.9% |
| Net Income (GAAP) | -$52.0M | $1.30B | $220.0M |
| EBITDA (Normalized) | $114.6M | $1.67B | $499.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $379.0M | $633.0M | $800.0M |
| Capital Expenditures (CapEx) | $220.0M | $170.0M | $300.0M |
| Free Cash Flow (FCF) | $159.0M | $463.0M | $500.0M |
| FCF Margin % | 2.2% | 7.0% | 7.5% |
| Return on Invested Capital (ROIC %) | -0.7% | 20.6% | 3.6% |
| Cash & Short-Term Equivalents | $787.0M | $1.01B | — |
| Total Debt (Short + Long Term) | $4.27B | $3.33B | $2.23B |
| Total Stockholders' Equity | $3.33B | $3.55B | $4.58B |